Search

Your search keyword '"Kazumasa Yokoyama"' showing total 290 results

Search Constraints

Start Over You searched for: Author "Kazumasa Yokoyama" Remove constraint Author: "Kazumasa Yokoyama"
290 results on '"Kazumasa Yokoyama"'

Search Results

251. Effects of a Transfusion with a Blood Substitute (Fluosol-DA, 20%) Part II: Human Cerebral Blood Flow

252. Cerebral dissecting aneurysms in patients with moyamoya disease

253. Inactivation and Elimination of Viruses during the Fractionation of an Intravenous Immunoglobulin Preparation: Liquid Heat Treatment and Polyethylene Glycol Fractionation

254. Immunosuppressive activity of corticosteroids incorporated in lipid emulsion

255. Perfluorooctyl bromide emulsion contrast agent for tumors

256. Synthesis of perfluorochemicals for use as blood substitutes, part II: electrochemical fluorination of partly fluorinated compounds

257. Inhibitory effect of bis(2-(E-2-alkenoylamino)ethyl) disulfides and 2-(E-octenoylamino)ethyl carbamoylmethyl sulfides on carrageenin-induced paw edema in rats

258. Synthesis of perfluorochemicals for use as blood substitutes. Part IV. Electrochemical fluorination of N-cycloalkyl-pyrrolidines and -piperidines

259. Study on Recombinant Hepatitis B Vaccine : Development of ELISA Methods for Detection of Contaminating Yeast Components in the Vaccine and Humoral Anti-yeast Component Antibody Developed in Humans and Guinea-pigs

260. Structures of potent antiulcerogenic compounds from

261. Inhibitory effect of bis(2-(E-2-octenoylamino)ethyl) disulfide and 2-(E-octenoylamino)ethyl carbamoylmethyl sulfide on various inflammation models

262. Antiulcerogenic Compounds Isolated from Chinese Cinnamon

263. Studies on pharmacological activation of human serum immunoglobulin G by chemical modification and active subfragments. IV. Induction of anti-inflammatory activity by chemical cleavage of interchain disulfide bonds in human immunoglobulin G and pharmacological activity of alkylated subfragments

264. Fate of perfluorochemicals in animals after intravenous injection or hemodilution with their emulsions

265. Heat treated intravenous immunoglobulin preparation

266. Studies on pharmacological activation of human serum immunoglobulin G(IgG) by chemical modification and active subfragments. VI. Anti-allergic activity of carboxamidemethylated Fc(CM-Fc) fragment from human serum IgG

267. Effect of deletion of epidermal growth factor-like domain on plasma clearance of pro-urokinase

268. Effect of perfluorochemical (PFC) emulsion on acute carbon monoxide poisoning in rats

270. Analysis of normal-appearing white matter of multiple sclerosis by tensor-based two-compartment model of water diffusion

271. Effect of N-3-(4-hydroxyphenyl)propionyl Pro-Pro-Gly-Ala-Gly on calcium-induced arrhythmias

272. The inhibitory effect of bis(2-((E)-2-octenoylamino)ethyl) disulfide on the cyclooxygenase pathway

273. A new antiarrhythmic peptide, N-3-(4-hydroxyphenyl)propionyl Pro-Hyp-Gly-Ala-Gly

274. Inhibitory activities and inhibition specificities of caffeic acid derivatives and related compounds toward 5-lipoxygenase

275. ChemInform Abstract: Structures of Potent Antiulcerogenic Compounds from Cinnamomum cassia

276. Use of a lipid emulsion as a novel carrier for corticosteroids

277. Retention of perfluorochemicals in circulating blood and organs of animals after intravenous injection of their emulsions

279. Comparison of efficacy, toxicity and pharmacokinetics of free adriamycin and adriamycin linked to oxidized dextran in rats

280. Studies on pharmacological activation of human serum IgG by chemical modification and active subfragments. V. Mechanism of anti-inflammatory action of carboxamide-methylated L-chain (Fr. I-L) and H-chain (Fr. I-H) from human serum IgG

281. Determination of particle size distribution of fluorocarbon emulsion by means of centrifugal sedimentation--a proposal for specifying the particle size distribution

282. Selective distribution of fibronectin to a tumor-cell line

283. Excretion of perfluorochemicals after intravenous injection of their emulsion

284. Inhibitory effect of 2-(E-2-alkenoylamino)ethyl alkyl sulfides on gastric ulceration in rats. I. Effect of 2-(E-2-alkenoylamino)ethyl carbamoylmethyl sulfides on gastric secretion and various ulceration models in rats

285. Further studies on the pharmacological effect of the anti-inflammatory compound, bis[2-(E-2-octenoylamino)ethyl] disulfide

286. Identification of autoimmune T cells among in vivo expanded CD25+ T cells in multiple sclerosis

287. Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study

289. Vision-Specific Anomia and Total Involvement of Splenium in Alexia Without Agraphia

290. Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro

Catalog

Books, media, physical & digital resources